Prothena Corp Public Ltd Co (PRTA) — 10-Q Filings

10-Q Filings (5)

• Prothena's Q2 Loss Widens to $66.7M Amid R&D Spend — Aug 4, 2025 Risk: high
  Prothena Corp Public Ltd Co reported a net loss of $66.7 million for the six months ended June 30, 2025, a significant increase from the $49.8 million net loss
• Prothena Corp Q1 2025 10-Q Filing — May 8, 2025 Risk: medium
  Prothena Corporation plc filed a 10-Q for the period ending March 31, 2025. The company, based in Dublin, Ireland, operates in the pharmaceutical preparations s
• Prothena Corp 10-Q Filing: Q3 2024 Update — Nov 12, 2024 Risk: medium
  Prothena Corporation plc filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nin
• Prothena Corp files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Prothena Corporation plc filed a 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first six month
• Prothena Corp. Reports Q1 2024 Results, Focus on Pipeline Advancement — May 8, 2024 Risk: medium
  PROTHENA CORP PUBLIC LTD CO (PRTA) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Prothena Corp. reported Q1 2024 results, with a focus on advanci

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX